Care navigation can supplement dementia care workforce, fill in care gaps: report
By
Kimberly Bonvissuto
Mar 23, 2023
Investing in care navigation — and care navigators — will help individuals living with Alzheimer’s disease and related dementias and their caregivers overcome barriers, according to a new report...
‘Alzheimer’s crisis’ intersecting with direct care workforce challenges, association says
By
Kimberly Bonvissuto
Mar 16, 2023
The nation is facing an “Alzheimer’s crisis” as the number of older adults in whom the disease is diagnosed continues to increase amid a shortage of direct care workers, according to the Alzheimer’s...
Sleep-initiation insomnia, sleep medication use may increase dementia risk
Mar 10, 2023
However, sleep-maintenance insomnia is tied to reduced dementia risk.
Vitamin D supplementation may cut dementia incidence
Mar 08, 2023
Any vitamin D supplement exposure was associated with a 40% lower dementia incidence.
High cardiovascular health tied to longer life expectancy free of disease
Mar 06, 2023
For those with high cardiovascular health level, no significant difference was seen in disease-free life expectancy based on socioeconomic status.
Inconsistent state regulations, staff training produce wide variations among states’ antipsychotic...
By
Kimberly Bonvissuto
Feb 28, 2023
Researchers are calling for a closer look at the use of antipsychotics among assisted living residents with dementia after a study found wide variations in prescribing patterns.
Advocates ‘appalled’ as CMS again says it will not cover monoclonal antibody treatments for Alzheimer’s
By
Kimberly Bonvissuto
Feb 24, 2023
Advocates of those living with Alzheimer’s disease are expressing disappointment that the Centers for Medicare & Medicaid Services on Wednesday rejected a request to expand its coverage of monoclonal...
More news for Wednesday, Feb. 22
By
Kimberly Bonvissuto
Feb 22, 2023
Congressman tells AG Garland that Esformes case is ‘political’ … FHCA unveils 2023 legislative priorities … Medicare advisers suggest tweak to coverage process for Alzheimer’s drugs … Schumer...
Bipartisan group pushes CMS to expand coverage for Alzheimer’s treatments
By
Kimberly Bonvissuto
Feb 21, 2023
Access to federally approved monoclonal antibody and other disease-modifying therapies for Alzheimer’s disease will be “extremely limited” unless the Centers for Medicare & Medicaid Services reconsiders...
Pioglitazone use linked to reduced dementia risk in T2DM
Feb 16, 2023
The reduction in risk was greatest for those with a history of ischemic heart disease or stroke.